REGAIN: a randomized controlled clinical trial of oxaloacetate for improving the symptoms of long COVID.
Saved in:
| Title: | REGAIN: a randomized controlled clinical trial of oxaloacetate for improving the symptoms of long COVID. |
|---|---|
| Authors: | Vernon SD; Bateman Horne Center, Salt Lake City, UT, United States., Rond C; Bateman Horne Center, Salt Lake City, UT, United States., Bell J; Bateman Horne Center, Salt Lake City, UT, United States., Butler B; Bateman Horne Center, Salt Lake City, UT, United States., Isolampi S; Bateman Horne Center, Salt Lake City, UT, United States., Otteson A; Bateman Horne Center, Salt Lake City, UT, United States., Phalwane P; Bateman Horne Center, Salt Lake City, UT, United States., Mower S; Department of Mechanical Engineering, University of Utah, Salt Lake City, UT, United States., Roundy S; Department of Mechanical Engineering, University of Utah, Salt Lake City, UT, United States., Kaufman DL; Center for Complex Diseases, Seattle, WA, United States., Cash AB; Terra Biological LLC, San Diego, CA, United States., Bateman L; Bateman Horne Center, Salt Lake City, UT, United States. |
| Source: | Frontiers in neuroscience [Front Neurosci] 2025 Jul 18; Vol. 19, pp. 1627462. Date of Electronic Publication: 2025 Jul 18 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101478481 Publication Model: eCollection Cited Medium: Print ISSN: 1662-4548 (Print) Linking ISSN: 1662453X NLM ISO Abbreviation: Front Neurosci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1662-4548 |
|---|---|
| DOI: | 10.3389/fnins.2025.1627462 |
